Erratum: Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial (PLoS ONE (2021) 15:4 (e0231095) DOI: 10.1371/journal.pone.0231095)

2Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

John Litt is not included in the author byline. John Litt should be listed as the eighth author and is affiliated with the Discipline of General Practice, Flinders University, Adelaide, South Australia, Australia. The contributions of this author are as follows: Conceptualization, Investigation, Methodology, Validation. David Edwards is not included in the author byline. David Edwards should be listed as the ninth author and is affiliated with SA Quitline, Cancer Council SA, Adelaide, South Australia, Australia. The contributions of this author are as follows: Conceptualization, Data curation, Investigation, Resources, Validation. The following information is missing from the Acknowledgments section: The authors would like to acknowledge the SA Quitline (and Cancer Council SA, as the provider of the Quitline) as the organisation that provided (and employed) the Counsellors who offered the pro-active call-back smoking cessation program through telephone advice.

Cite

CITATION STYLE

APA

Carson-Chahhoud, K. V., Smith, B. J., Peters, M. J., Brinn, M. P., Ameer, F., Singh, K., … Esterman, A. J. (2021, December 1). Erratum: Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial (PLoS ONE (2021) 15:4 (e0231095) DOI: 10.1371/journal.pone.0231095). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0262188

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free